Enzon

Enzon Pharmaceuticals is a biopharmaceutical company dedicated to developing, manufacturing, and commercializing critical drugs for patients with cancer and other life-threatening diseases. Enzon has a portfolio of four marketed products: ONCASPAR®, DEPOCYT®, ABELCET®, and ADAGEN®.